GPCR
Structure Therapeutics Inc.
31.30$
-4.3%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +122.8% | -5.1% | +107.1% | -1.5% | -3.2% | -4.1% | -5.8% | +1.9% | +90.3% | -4.8% | -5.5% | |
| – | +125.6% | -5.1% | +108.7% | -1.5% | -3.5% | -4.7% | -5.9% | +1.8% | +92.9% | -5.1% | -8.0% | |
| – | +156.3% | -24.6% | +290.1% | -54.9% | -1.5% | -10.3% | -3.4% | -30.0% | +677.0% | -60.5% | -13.8% | |
| – | +127.5% | -6.6% | +112.4% | -1.3% | -3.5% | -5.3% | -6.0% | +1.6% | +81.0% | +0.9% | -7.9% | |
| – | +24.1% | -5.7% | -5.1% | +40.1% | +5.7% | +8.9% | +5.8% | +40.1% | +8.7% | -9.6% | +16.4% | |
| – | +23.1% | -4.7% | -3.9% | +47.6% | +7.7% | +1.3% | +7.0% | +47.4% | +10.0% | -10.0% | +16.0% | |
| – | +76.3% | +11.1% | +1.8% | +5.1% | -0.8% | +45.5% | +7.8% | +5.2% | +2.7% | -9.3% | -0.5% | |
| – | +42.9% | +37.9% | -66.2% | +282.4% | -5.0% | +8.5% | +3.2% | +98.0% | -22.1% | -43.6% | +42.3% | |
| – | +134.7% | -5.1% | +114.3% | -2.6% | -3.6% | -4.6% | -6.4% | -0.3% | +96.9% | -4.6% | -6.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +21.1% | +0.4% | +6.1% | +15.8% | +0.1% | +0.1% | +1.0% | +1.0% | +1.2% | +22.4% | +0.3% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.